Your browser doesn't support javascript.
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants.
Tu, Bin; Wang, Huiyuan; An, Xinran; Qu, Jingkun; Li, Qianqian; Gao, Yanrong; Shi, Mingjie; Qiu, Hong; Huang, Yongzhuo.
  • Tu B; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Wang H; University of Chinese Academy of Sciences, Beijing 100049, China.
  • An X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Qu J; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Li Q; University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA.
  • Gao Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shi M; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Qiu H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Huang Y; Nanchang University College of Pharmacy, Nanchang 330006, China.
Acta Pharm Sin B ; 12(7): 3187-3194, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1676402
ABSTRACT
The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery.Image 1.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Acta Pharm Sin B Year: 2022 Document Type: Article Affiliation country: J.apsb.2022.01.019

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Acta Pharm Sin B Year: 2022 Document Type: Article Affiliation country: J.apsb.2022.01.019